Tekcapital plc Private Placement for Belluscura plc (3460O)
17 5월 2018 - 3:00PM
UK Regulatory
TIDMTEK
RNS Number : 3460O
Tekcapital plc
17 May 2018
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014
("MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE
INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
17 May 2018
Tekcapital plc
("Tekcapital" or the "Company")
Private Placement for Belluscura plc
Tekcapital plc (AIM: TEK), the UK intellectual property (IP)
investment group focused on creating marketplace value from
university technology, is pleased to announce that following the
placement announced on 14 February 2018, Belluscura plc
("Belluscura") has completed a further tranche in the private
placement to raise an additional US$603,000 through the issue of
equity (the "Private Placement"), through Dowgate Capital
Stockbrokers, and has converted loans equal to approximately
US$78,000 to equity under the same terms as the Private
Placement.
This Private Placement was priced at US$0.18 (13p) per share,
giving Belluscura a post-money valuation of approximately US$4.3
million. The Private Placement will continue to remain open to
enable current shareholders and additional investors to
participate.
Belluscura was established in the UK in December 2015 to provide
premium proprietary medical devices at affordable prices. It has
already launched three products with two more products in
development. The proceeds of the Private Placement will be used for
further investment in Belluscura's products in development,
specifically the CURV(TM) oxygen concentrator and Snap III(TM)
level of consciousness monitor, and for general working capital
purposes.
Tekcapital's ownership interest in Belluscura is now 8,129,488
shares, representing approximately 33% of the issued share
capital.
For further information, please contact:
Tekcapital Plc
Clifford M. Gross, Ph.D. info@tekcapital.com
Allenby Capital Limited (Nominated Adviser
& Joint Broker) +44 (0) 20 3328 5656
Jeremy Porter / Alex Brearley
Dowgate Capital Stockbrokers (Joint Broker) +44 (0) 1293 517744
David Poutney / James Serjeant
Walbrook PR Ltd +44 (0) 20 7933 8780
Paul Cornelius / Helen Cresswell / Sam tekcapital@walbrookpr.com
Allen
Tekcapital plc - The World's Largest University Network for Open
Innovation
Tekcapital's objective is to create value from investing in new,
university-developed intellectual properties. Additionally, using
its proprietary discovery search engine, linked to 4,500+
universities in 160 countries, coupled with expert scientific
review, Tekcapital provides a range of IP investment services to
make it easy for organisations to find, evaluate, acquire and
license university-developed technology. Tekcapital plc is quoted
on the AIM market of the London Stock Exchange (AIM: symbol TEK)
and is headquartered in Oxford, in the UK. For more information,
please visit www.tekcapital.com
LEI: 213800GOJTOV19FIFZ85
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCAFMRTMBBBBPP
(END) Dow Jones Newswires
May 17, 2018 02:00 ET (06:00 GMT)
Tekcapital (LSE:TEK)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Tekcapital (LSE:TEK)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024